Affinity's weight loss program involves reviewing your medical history, simple labs, and a Medical Provider consultation. All of your medication and supplies are shipped to your door for weekly self-injections. 

Disqualifying conditions include a history of Diabetes, Kidney Disease, Gallbladder Disease, Pancreatitis, Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Syndrome Type 2, Thyroid Nodule that has not been evaluated, Pregnant or Breastfeeding

Medical studies report patients losing 15-20% of their body weight on average after one year. Results vary based on medication, dosage, starting weight, activity levels and other factors.

*Clinical studies show patients treated with GLP-1s experienced an average weight loss of 14.9-20.9% of their total body weight after 68-72 weeks. Results for patients treating with GLP-1 will vary based on a number of medical and other factors like your individual health profile, starting weight, commitment to lifestyle change and adherence to medication regimen. You should discuss these factors with your Affinity medical provider before beginning treatment.

Depending on your dosage, programs typically last  3-5 months. 

Programs starting at $249 per month. Our all-in pricing covers your medications, supplies, shipping & handling, follow-up consultations and follow-up lab work. We never charge a membership fee.

*HSA/FSA accepted. Insurance does not typically cover these medications.

Typically, insurance does not reimburse or cover the cost of Compounded Semaglutide treatment. However, we do accept HSA and FSA cards for treatment and services.

Yes! Compounded medications are real medications. They may contain the same active ingredients as FDA-approved medications.

All medications are prepared in State Board of Pharmacy licensed compounding pharmacies or FDA-licensed 503(b) Outsourcing Facilities, ensuring the use of only the highest quality ingredients. Although these facilities are highly regulated, the compounded medications are not FDA-approved, as they are tailored to an individual provider's prescription for a specific patient.

Medically approved clients may be offered prescription injections of Semaglutide, which are gradually absorbed by the body over a day or week to help reduce appetite and cravings. 

Please note, the compounded medication you may receive is not affiliated with Novo Nordisk™ or their brand-name drugs Wegovy® and Ozempic®.

*Compounded medications are prepared at the direction of your Affinity healthcare provider and are not governed by the FDA.

Potential side effects include abdominal discomfort, constipation, diarrhea, nausea, vomiting, fatigue, headache; these symptoms may improve over time. Patients have found side effects may decrease by maintaining proper hydration and eating before injection.

During your first consultation with an Affinity Medical Provider, you go over your lab results and medical history together.

When you begin a program with Affinity, you receive check-ins from your Patient Care Coordinator and your Affinity Medical Provider reviews your periodic lab results.

You'll have consultations annually with your Affinity Medical Provider and as needed.

No. GLP-1s are not recommended during pregnancy or while trying to conceive, as there’s not enough safety data. Women are typically advised to discontinue them at least 1–2 months before attempting to conceive.

Some women experience changes in menstruation, often due to rapid weight loss or changes in insulin levels. It’s not a direct side effect, but hormonal shifts from weight loss can influence cycles.

Yes, they can be beneficial. GLP-1s may improve insulin sensitivity and support weight loss, both of which can help regulate cycles and improve symptoms in women with PCOS.

Not directly. However, rapid weight loss of any kind can sometimes lead to temporary hair shedding. It’s not due to the GLP-1 itself. Hair loss is temporary, resolving once weight stabilizes and nutrient intake is optimized.